Get the Stockscreener App
1.69
1.17%
-0.02
Health Catalyst Inc stock is traded at $1.69, with a volume of 400.42K.
It is down -1.17% in the last 24 hours and down -25.88% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$1.71
Open:
$1.68
24h Volume:
400.42K
Relative Volume:
0.25
Market Cap:
$127.18M
Revenue:
$302.48M
Net Income/Loss:
$-265.26M
P/E Ratio:
-0.4548
EPS:
-3.716
Net Cash Flow:
$-2.76M
1W Performance:
+6.29%
1M Performance:
-25.88%
6M Performance:
-13.33%
1Y Performance:
-48.79%
1-Day Range:
$1.67
$1.71
1-Week Range:
$1.546
$1.76
52-Week Range:
$0.9551
$3.615
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, TXG, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.69 | 122.67M | 302.48M | -265.26M | -2.76M | -3.716 |
VEEV
Veeva Systems Inc
|
275.09 | 40.70B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.73 | 11.78B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
64.62 | 12.03B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
62.65 | 8.32B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
96.07 | 8.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Health Catalyst Shares Fall After Canaccord Genuity Downgrade - marketscreener.com
This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
HCAT Downgraded by Canaccord Genuity -- Price Target Lowered to $1.80 - GuruFocus
HCAT Looks 60.3% Undervalued on GF Value™ Despite Market Concerns - GuruFocus
Health Catalyst (HCAT) Q2 2026 Earnings Call Transcript - AOL.com
Health Catalyst, GitLab, Elastic, and Marqeta Shares Plummet, What You Need To Know - Yahoo Finance
5 Must-Read Analyst Questions From Health Catalyst’s Q2 Earnings Call - Yahoo Finance
Health Catalyst (HCAT) group led by Clint Coghill reports 9.6% ownership stake - Stock Titan
HCAT Maintains by Wells Fargo -- Price Target Lowered to $1.50 - GuruFocus
Wells Fargo & Company Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price - MarketBeat
Health Catalyst sells VitalWare for $147Mn - Outsource Accelerator
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Health Catalyst: Q2 Earnings Snapshot - AOL.com
HCAT Maintained by Citigroup -- Price Target Lowered to $2.00 - GuruFocus
Health Catalyst (NASDAQ:HCAT) Price Target Cut to $2.00 by Analysts at Citigroup - MarketBeat
HCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline - Yahoo Finance
Why Health Catalyst (HCAT) Shares Are Trading Lower Today - finance.yahoo.com
Health Catalyst (NASDAQ:HCAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Health Catalyst Shares Tumble Overnight: What Investors Need to Know - webull.com
Health Catalyst, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Health Catalyst sells Vitalware unit, retires credit facility By Investing.com - Investing.com Nigeria
Health Catalyst Inc (HCAT) (Q2 2026) Earnings Call Highlights: D - GuruFocus
Health Catalyst 2Q Loss $40.5M >HCAT - Moomoo
Health Catalyst Reports Second Quarter 2026 Results - The Manila Times
Is Health Catalyst Inc (HCAT) Positioned for Recovery After Q2 E - GuruFocus
Health Catalyst earnings missed by $0.58, revenue topped estimates - Investing.com Canada
Health Catalyst Q2 Earnings Call Highlights - MarketBeat
HCAT Looks 53.0% Undervalued on GF Value™ Despite Earnings Chall - GuruFocus
Earnings call transcript: Health Catalyst posts Q2 2026 revenue beat, shares sink - Investing.com
Health Catalyst sells Vitalware unit, retires credit facility - Investing.com
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Health Catalyst, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates - Yahoo! Finance Canada
M&A: Health Catalyst Closes $147M Sale of Vitalware to Med-Metrix - HIT Consultant
Health Catalyst, Inc. 2026: Revenue $70.49M, EPS ($0.55) — 10-Q Summary - TradingView
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Health Catalyst (NASDAQ:HCAT) Exceeds Q2 CY2026 Expectations But Stock Drops 25.5% - Barchart.com
Q2 2026 Health Catalyst Inc Earnings Call Transcript - GuruFocus
Health Catalyst (NASDAQ: HCAT) books $151.6M loss and $147M Vitalware sale - Stock Titan
HEALTH CATALYST ($HCAT) Releases Q2 2026 Earnings - Quiver Quantitative
Health Catalyst (Nasdaq: HCAT) sells Vitalware, ends credit facility debt - Stock Titan
Health Catalyst, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company - marketscreener.com
BRIEF-Health Catalyst Q2 Net Income USD -40.537 Million - TradingView
Health Catalyst, Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2026 - marketscreener.com
Health Catalyst Tries To Reset With A Vitalware Sale - Finimize
Health Catalyst (HCAT) Q2 Earnings Report Preview: What To Look For - Barchart.com
Health Catalyst, Inc. expected to post earnings of 3 cents a shareEarnings Preview - TradingView
nCino, Braze, ServiceNow, Health Catalyst, and Palo Alto Networks Shares Are Soaring, What You Need To Know - Yahoo Finance
Med-Metrix, LLC completed the acquisition of Vitalware, LLC from Health Catalyst, Inc.. - marketscreener.com
Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026 - The Manila Times
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.03%
1.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):